Ethics Evaluation Committee (CEEI/IRB)

  • Modified on: 04/07/2024
  • Published on: 02/07/2021
  • Reading time: 2 min
  • Ethics

The mission of the Inserm Ethics Evaluation Committee (CEEI) is to provide its opinion on research projects that directly or indirectly involve humans in the biological and medical area (health research), but also in social sciences and humanities. Through its procedures, the CEEI supports investigators to make ethical consideration an integral part of the scientific approach.

The Inserm Ethics Evaluation Committee (CEEI) is a research ethics committee (REC) as defined by the Council of Europe. The CEEI is registered with the Office for Human Research Protections (OHRP) of the United States Department of Health, and is therefore an Institutional Review Board (IRB00003888).

The CEEI is attached for administrative purposes to the Inserm Directorate General, but its organization and decisions are entirely independent.

Composition

The CEEI is a multidisciplinary committee whose members are appointed by decision of the Chairman and CEO of Inserm. These include members with health expertise, members with social sciences and humanities expertise, a methodologist, a legal expert with expertise in clinical research, and a patient association representative. One of the members of the CEEI chairs the committee.

  • Christine Dosquet (Chair), MD, PhD, HDR
  • Adrienne Anginot (coordinator), PhD Inserm
  • Emilie Bujeaud (assistant), Inserm
  • Philippe Amiel, sociologist and health lawyer, Inserm Unit 1123
  • Bruno Clément, biologist, Director of Inserm Unit 991
  • Agnès Dumas, sociologist, Inserm Unit 1123
  • Noémie Merleau-Ponty, anthropologist, IRIS, CNRS
  • Marie Moreau, Clinical Research Associate (Haematology), Grenoble University Hospital
  • Marie-Christine de la Morlais, Alliance for Rare Diseases
  • Mouna Mouline, patient researcher, Lyon 2 University
  • Marie Préau, Professor of Social Psychology of Health, Inserm Unit 1296
  • Nathalie Rochet, medical researcher, Inserm Unit 1091
  • Perrine Roux, public health researcher, Inserm Unit 912
  • Raphaël Porcher, Biostatistician; APHP and Inserm Unit 1153
  • Isabelle Sermet-Gaudelus, doctor, cystic fibrosis reference centre, APHP and Inserm Unit 1151
  • Murielle Sevenne, patient researcher, Lyon 2 University
  • Michèle Souyri, Inserm researcher, Inserm Unit 1131
CONTACT